Target intelligence / Profile preview

Sorbitol dehydrogenase pseudogene

Molecular classification
Other (Pseudogene)
01

Overview

Sorbitol dehydrogenase pseudogene (ENSG00000270425; LOC100419644) is a genomic DNA sequence resembling the functional sorbitol dehydrogenase gene but does not encode an active protein product. Pseudogenes arise by duplication or retrotransposition and typically lack regulatory elements or functional open reading frames, rendering them transcriptionally inactive or non-functional at the protein level. Although the active sorbitol dehydrogenase gene (SORD) plays a central role in the polyol pathway, this pseudogene does not participate in enzymatic activities and is not considered a therapeutic target. This entity is not considered a therapeutic target, druggable protein, or biomarker. There is nothing misspelled, but this gene should not be treated as a functional molecular target. If the intent was to refer to the active SORD gene, a different identifier (such as ENSG00000128052 for SORD) should be used. Related, the SORD gene (not the pseudogene) is an enzyme (oxidoreductase) with roles in glucose metabolism and the development of diabetic complications, but none of these properties apply to this pseudogene.

Other names
LOC100419644sorbitol dehydrogenasepseudogene

Beyond the preview

Go deeper on Sorbitol dehydrogenase pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sorbitol dehydrogenase pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call